Collegium Pharmaceutical (COLL) Forms DEF 14A Filing on April 10

Collegium Pharmaceutical (COLL) has filed a DEF 14A with the SEC dated April 10. This filing includes essential information regarding upcoming shareholder meetings and proposals for the company's governance. It is a standard procedure in ensuring compliance with regulatory requirements. Market participants will review this filing to assess any potential impacts on shareholder relations or corporate strategy.